V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290008259 | 290007251 | 1.8 | 45 | Palliative (P) | 2016-04-17 | 2016-05-07 | Capecitabine + Oxaliplatin 21day | N | null | 290021638 | CAV |
| 290008260 | 290005330 | null | 74.8 | Palliative (P) | 2019-06-21 | 2019-06-21 | CETUXIMAB + RT | N | Y | 290021673 | CAPECITABINE + TEMOZOLOMIDE |
| 290008261 | 290005334 | 1.64 | 66.1 | Curative (C) | 2017-04-01 | 2017-05-13 | LANREOTIDE | N | N | 290021710 | FLUOROURACIL + MITOMYCIN |
| 290008262 | 290005339 | 1.77 | null | Neo-adjuvant (N) | 2017-02-09 | 2017-02-23 | Capecitabine | null | null | 290021733 | PERTUZUMAB + TRASTUZUMAB |
| 290008263 | 290005346 | 1.6 | 65.8 | null | null | 2017-02-27 | Cetuximab 7 day (Cycle 1) | N | N | 290021744 | LANREOTIDE |
| 290008264 | 290005350 | 1.61 | 54.9 | Palliative (P) | 2019-01-16 | 2019-01-16 | Capecitabine + Oxaliplatin 21day | N | N | 290021748 | CETUXIMAB + MDG |
| 290008265 | 290005367 | 1.58 | 58.2 | Palliative (P) | 2017-04-02 | 2017-07-25 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290021806 | CAPECITABINE |
| 290008266 | 290005370 | null | 78.2 | Curative (C) | 2017-12-01 | 2017-12-03 | Trial Unspecified | N | N | 290021820 | R-EPOCH |
| 290008267 | 290005375 | 1.61 | 84.5 | Palliative (P) | 2018-03-14 | 2018-04-19 | OCTREOTIDE | N | N | 290021863 | IBRUTINIB |
| 290008268 | 290005383 | 1.58 | 77.5 | Not known (9) | 2018-11-03 | 2018-11-30 | Capecitabine + Oxaliplatin 21day | N | null | 290021886 | Y-90 |
| 290008269 | 290005390 | 1.6 | 78.2 | Palliative (P) | 2016-11-07 | 2016-11-08 | CAPECITABINE + MITOMYCIN + RT | N | N | 290021906 | OCTREOTIDE |
| 290008270 | 290005393 | 1.68 | 50 | Palliative (P) | 2018-07-17 | 2018-07-21 | Docetaxel 75mg/m2 (21 day) | 2 | Y | 290021951 | PACLITAXEL |
| 290008271 | 290007286 | null | 63.2 | Palliative (P) | 2016-10-31 | 2016-11-06 | Carboplatin + Etoposide iv&po | N | N | 290021981 | INTERAACT TRIAL |
| 290008272 | 290005409 | 1.61 | 54.5 | Palliative (P) | 2016-11-18 | 2016-11-20 | Capecitabine + Cisplatin | 02 | N | 290022034 | OCTREOTIDE |
| 290008273 | 290005421 | 1.68 | 45.9 | Palliative (P) | null | 2018-01-26 | Capecitabine | N | N | 290022089 | INTERAACT TRIAL |
| 290008274 | 290005424 | 1.73 | 105.5 | null | 2018-10-23 | 2018-11-23 | Carboplatin AUC 2 - 5 | N | null | 290022112 | CAPECITABINE + OXALIPLATIN |
| 290008275 | 290008419 | null | null | Palliative (P) | 2018-08-18 | 2018-12-22 | Carbo F | N | Y | 290022185 | TRASTUZUMAB + VINORELBINE |
| 290008276 | 290005433 | 1.71 | 0 | Palliative (P) | 2018-07-12 | 2018-12-27 | Bevacizumab 7.5mg/kg | N | N | 290022192 | CAPECITABINE + OXALIPLATIN |
| 290008277 | 290005436 | 1.89 | 99.4 | null | 2018-02-04 | 2018-02-15 | CARBOPLATIN + ETOPOSIDE | N | N | 290022214 | CAPECITABINE + OXALIPLATIN |
| 290008278 | 290005449 | 1.52 | null | Adjuvant (A) | 2016-11-29 | 2016-11-29 | Capecitabine + Cisplatin | N | Y | 290022260 | CAPECITABINE + OXALIPLATIN |
| 290008279 | 290005451 | 1.72 | 66 | Palliative (P) | 2017-11-05 | 2017-11-27 | Trial Unspecified | 2 | N | 290022278 | CETUXIMAB |
| 290008280 | 290005455 | null | 62.9 | Adjuvant (A) | 2018-11-01 | 2018-11-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290022286 | CAPECITABINE |
| 290008281 | 290005471 | 1.52 | 94 | Palliative (P) | 2016-03-25 | 2016-03-28 | Capecitabine + Oxaliplatin 21day | 02 | N | 290022373 | TRIAL |
| 290008282 | 290005474 | 1.74 | 74.9 | Curative (C) | 2015-03-02 | 2015-03-08 | Capecitabine (14 day) + Irinotecan | 02 | Y | 290022389 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008283 | 290005475 | 1.79 | 116 | Palliative (P) | 2013-12-06 | 2014-01-29 | CARBOPLATIN + PACLITAXEL | N | null | 290022390 | OCTREOTIDE |
| 290008284 | 290007322 | 1.63 | 60.3 | Palliative (P) | 2017-07-29 | 2017-07-29 | REGORAFENIB | 02 | N | 290022420 | Y-90 |
| 290008285 | 290005492 | 1.78 | 41 | Curative (C) | 2017-11-18 | 2017-12-06 | CAPECITABINE + RT | 02 | N | 290022433 | CAPECITABINE |
| 290008286 | 290005504 | 1.62 | 80.4 | Curative (C) | 2015-12-08 | 2016-01-06 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | 290022501 | CARBOPLATIN |
| 290008287 | 290005516 | 1.78 | null | Palliative (P) | 2017-12-20 | 2018-06-13 | Trial Unspecified | N | N | 290022527 | CARBOPLATIN + CETUXIMAB + FU |
| 290008288 | 290007341 | 1.61 | 48.1 | Curative (C) | 2019-02-15 | 2019-02-15 | CAPECITABINE + OXALIPLATIN | N | N | 290022602 | CARBOPLATIN |
| 290008289 | 290007344 | 1.71 | null | null | 2014-09-25 | 2014-10-29 | Capecitabine + Oxaliplatin 14day | null | null | 290022610 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008290 | 290008314 | 1.91 | 83.6 | null | 2017-03-14 | 2017-03-19 | Capecitabine + Cisplatin | N | N | 290022612 | FLUOROURACIL + MITOMYCIN |
| 290008291 | 290005543 | 1.7 | 55.6 | Palliative (P) | 2017-12-18 | 2018-04-04 | ICON8 TRIAL | 02 | N | 290022648 | CISPLATIN + RT |
| 290008292 | 290005549 | 1.57 | 83 | Palliative (P) | 2019-04-10 | 2019-04-19 | Cetuximab + Radiotherapy Maint | N | N | 290022662 | NIVOLUMAB |
| 290008293 | 290005558 | 0 | 80.8 | Curative (C) | 2014-10-01 | 2014-10-01 | CAPECITABINE + TEMOZOLOMIDE | N | N | 290022722 | CISPLATIN + RT |
| 290008294 | 290007357 | null | 44.1 | Adjuvant (A) | 2018-05-04 | 2018-06-08 | Docetaxel | N | N | 290022734 | CAPECITABINE + OXALIPLATIN |
| 290008295 | 290005560 | null | 64.9 | Palliative (P) | 2015-10-13 | 2015-12-21 | Capecitabine | N | N | 290022741 | CAPECITABINE |
| 290008296 | 290005564 | null | 77.7 | Adjuvant (A) | null | 2018-10-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290022763 | CAPECITABINE + CARBOPLATIN |
| 290008297 | 290005567 | 1.66 | 67.5 | Palliative (P) | null | 2015-10-10 | MITOMYCIN | N | N | 290022776 | CAPECITABINE + CISPLATIN |
| 290008298 | 290005568 | 1.83 | 62 | Curative (C) | 2018-04-16 | 2018-04-21 | Cetuximab + Oxaliplatin + MdG Load | 2 | N | 290022780 | CETUXIMAB |
| 290008299 | 290005570 | 1.73 | 68 | Palliative (P) | 2017-02-24 | 2017-02-25 | Capecitabine + Mitomycin | Y | N | 290000136 | DACARBAZINE |
| 290008300 | 290005573 | 1.63 | null | Palliative (P) | 2017-01-31 | 2017-02-01 | Capecitabine | N | null | 290000851 | CETUXIMAB + MDG |
| 290008301 | 290005577 | null | 38.8 | Palliative (P) | 2017-04-05 | 2017-04-05 | MCX | 2 | N | 290001592 | CARBO + FLUOROURACIL |
| 290008302 | 290005582 | 1.84 | 83.5 | Curative (C) | 2019-10-04 | 2019-10-07 | OCTREOTIDE | 02 | Y | 290002606 | CISPLATIN + ETOPOSIDE |
| 290008303 | 290005589 | null | 50 | Palliative (P) | 2015-03-23 | 2015-04-01 | R CODOX M | 01 | null | 290006785 | IBRUTINIB |
| 290008304 | 290005603 | 1.77 | 93 | Curative (C) | 2017-07-02 | 2017-08-10 | CHOP R - 21 days | 02 | Y | 290010785 | CETUXIMAB |
| 290008305 | 290005604 | 1.67 | 87.1 | Palliative (P) | 2018-10-06 | 2018-10-06 | Methotrexate intrathecal | 2 | Y | 290011095 | CARBOPLATIN |
| 290008306 | 290005607 | 1.8 | 72.7 | Palliative (P) | 2018-08-16 | 2018-08-22 | LANREOTIDE | N | N | 290011395 | CARBOPLATIN + PACLITAXEL |
| 290008307 | 290005614 | 1.6 | 57 | Curative (C) | 2017-05-24 | 2017-07-11 | LANREOTIDE | N | N | 290013573 | CISPLATIN + RT |
| 290008308 | 290005620 | 1.74 | 51.6 | Palliative (P) | 2018-05-06 | 2018-07-27 | Capecitabine | 02 | N | 290015077 | CARBOPLATIN |